Mindfulness‐based stress reduction for women diagnosed with breast cancer

LK Schell, I Monsef, A Wöckel… - Cochrane Database of …, 2019 - cochranelibrary.com
Background Breast cancer is the most common cancer in women. Diagnosis and treatment
may drastically affect quality of life, causing symptoms such as sleep disorders, depression …

AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2019

N Ditsch, M Untch, M Thill, V Müller, W Janni, US Albert… - Breast Care, 2019 - karger.com
For almost 20 years, the Breast Committee of the German Gynecological Oncology Group
(Arbeitsgemeinschaft Gynäkologische Onkologie, AGO) has been preparing and updating …

AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021

N Ditsch, C Kolberg-Liedtke, M Friedrich, C Jackisch… - Breast Care, 2021 - karger.com
The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German
Gynecological Oncology Group, AGO) presents the 2021 update of the evidence-based …

[HTML][HTML] Effects of guideline adherence in primary breast cancer–a 5-year multi-center cohort study of 3976 patients

A Wöckel, C Kurzeder, V Geyer, I Novasphenny… - The Breast, 2010 - Elsevier
BACKGROUND: The aim of that study was to analyze the impact of German-S3-breast
cancer guideline adherence on clinical outcomes. METHODS: A retrospective study …

[HTML][HTML] Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages–a self …

I Montalbán del Barrio, C Penski, L Schlahsa… - … for immunotherapy of …, 2016 - Springer
Abstract Background Ovarian cancer (OvCA) tissues show abundant expression of the
ectonucleotidases CD39 and CD73 which generate immunomodulatory adenosine, thereby …

[HTML][HTML] Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment

M Haake, B Haack, T Schäfer, PN Harter… - Nature …, 2023 - nature.com
Immune checkpoint blockade therapy is beneficial and even curative for some cancer
patients. However, the majority don't respond to immune therapy. Across different tumor …

[HTML][HTML] Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer

T Stüber, R Monjezi, L Wallstabe… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Immunotherapy with chimeric antigen receptor (CAR)-engineered T-cells is
effective in some hematologic tumors. In solid tumors, however, sustained antitumor …

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2020

N Ditsch, M Untch, C Kolberg-Liedtke, C Jackisch… - Breast Care, 2020 - karger.com
For the last 18 years, the Breast Committee of the Arbeitsgemeinschaft Gynäkologische
Onkologie (German Gynecological Oncology Group, AGO) has been preparing and …

[HTML][HTML] Analysis of microRNAs in exosomes of breast cancer patients in search of molecular prognostic factors in brain metastases

CJ Curtaz, L Reifschläger, L Strähle… - International Journal of …, 2022 - mdpi.com
Brain metastases are the most severe tumorous spread during breast cancer disease. They
are associated with a limited quality of life and a very poor overall survival. A subtype of …

[HTML][HTML] Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: a systematic review and meta-analysis

A Glechner, A Wöckel, G Gartlehner, K Thaler… - European Journal of …, 2013 - Elsevier
BACKGROUND: The Z0011-study, a landmark randomised controlled trial (RCT) challenged
the benefits of complete axillary lymph node dissection (ALND) compared with sentinel …